However, FLI, liver stiffness, APRI, and CK18 fragments have largely been proven to represent easy and reliable screening tools to identify NAFLD/NASH in epidemiological studies. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.